ArticleCell & bioscience2020

Senolytic compounds control a distinct fate of androgen receptor agonist- and antagonist-induced cellular senescent LNCaP prostate cancer cells.

Thanakorn Pungsrinont et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.